Summary
The FDA has approved a new Merck pill, Lipfendra, which drastically reduces cholesterol by blocking the PCSK9 liver protein, previously only achievable with expensive injectable drugs. This oral medication offers a new treatment option for patients whose cholesterol remains high despite statin use.